IMRN: Rasio rega marang wutah bathi resik Immuron Ltd
The valuation-to-earnings growth ratio for Immuron Limited (IMRN) is based on a loyal customer base and US government contracts for Travelan. The operating model relies on an exclusive B2C health protection brand, while innovation centers on the creation of safe oral antibodies derived from colostrum. The current value is fixed at 0.00, which allows for an assessment of the asset's fundamental attractiveness through the lens of business expansion rates.
Rincian metrik lan analitis perusahaan Immuron Limited (IMRN)
The metric is calculated by dividing the P/E ratio by the company's earnings growth rate. A value below one indicates a fundamental undervaluation of the asset relative to its expansion. For Immuron Limited (IMRN), the limited market size for colostrum-based products constrains aggressive revenue growth. Analysis of the PEG ratio chart helps determine whether the scaling potential offsets the current share price.
